In one paragraphArticle in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
8 authors.
Hannah RobertsNeuroscience Institute, Dale and Deborah Smith Center for Alzheimer's Research and Treatment, Dept of Neurology; Southern Illinois University School of Medicine, Springfield, IL, USA.
Yimin FangNeuroscience Institute, Dale and Deborah Smith Center for Alzheimer's Research and Treatment, Dept of Neurology; Southern Illinois University School of Medicine, Springfield, IL, USA.ORCID 0000-0001-9270-5857 Kathleen QuinnNeuroscience Institute, Dale and Deborah Smith Center for Alzheimer's Research and Treatment, Dept of Neurology; Southern Illinois University School of Medicine, Springfield, IL, USA.
Tiarra HillNeuroscience Institute, Dale and Deborah Smith Center for Alzheimer's Research and Treatment, Dept of Neurology; Southern Illinois University School of Medicine, Springfield, IL, USA.ORCID 0009-0000-7995-842X Mackenzie R PeckNeuroscience Institute, Dale and Deborah Smith Center for Alzheimer's Research and Treatment, Dept of Neurology; Southern Illinois University School of Medicine, Springfield, IL, USA.ORCID 0000-0002-2611-1150 Andrzej BartkeDept of Internal Medicine; Southern Illinois University School of Medicine, Springfield, IL, USA.ORCID 0000-0002-2569-557X Kevin N HascupNeuroscience Institute, Dale and Deborah Smith Center for Alzheimer's Research and Treatment, Dept of Neurology; Southern Illinois University School of Medicine, Springfield, IL, USA.ORCID 0000-0001-6604-1874 Erin R HascupNeuroscience Institute, Dale and Deborah Smith Center for Alzheimer's Research and Treatment, Dept of Neurology; Southern Illinois University School of Medicine, Springfield, IL, USA.ORCID 0000-0003-1037-0809 Funding
Sequelae of SARS-CoV-2 Infection in Alzheimer's DiseaseR01AG061937 · NIA · SOUTHERN ILLINOIS UNIVERSITY SCH OF MED · PI HASCUP, ERIN R · 2018 to 2022
$4.0MGlutamate neurotransmission in Alzheimer's disease progressionR01AG057767 · NIA · SOUTHERN ILLINOIS UNIVERSITY SCH OF MED · PI HASCUP, ERIN R · 2018 to 2022
$3.2MNIA NIH HHS R01 AG057767NIA NIH HHS R01 AG061937
6 · The paper itselfAbstract
Alzheimer's disease (AD) disproportionately affects women, yet most preclinical research studies are male-centric. We performed lifespan analyses of male and female AD mouse models (APP/PS1 and APP
Indexed as
amyloid-betaKaplan-Meier estimatesurvival curve
Identifiers
PMID39464050
PMCPMC11507819
What Socratic holds
Textmetadata
LicenceCC BY-ND
Read underepoch 390